NRAS and tumor of salivary gland: PIK3CA mutations were found in 59% of HRAS-mutant salivary gland tumors but due to the limited number of KRAS- and NRAS-mutant tumors of this lineage this was not significantly different, but was more prevalent than in other HRAS-mutant cancers (p<0.05).